A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's disease.
Saved in:
| Title: | A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's disease. |
|---|---|
| Authors: | Tosefsky K; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.; MD/PhD Program, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Lam JS; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada., Wang YN; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.; Faculty of Land and Food Systems, Food, Nutrition and Health, University of British Columbia, Vancouver, BC, Canada., Keymanesh S; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada., Kuan AJ; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.; Faculty of Medicine, Department of Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada., Metcalfe-Roach A; Faculty of Science, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.; Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada., Cirstea MS; Faculty of Science, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.; Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada., Sacheli MA; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada., Brett Finlay B; Faculty of Science, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.; Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.; Faculty of Medicine, Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada., Cohen TR; Faculty of Land and Food Systems, Food, Nutrition and Health, University of British Columbia, Vancouver, BC, Canada., Appel-Cresswell S; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.; Faculty of Medicine, Department of Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada. |
| Source: | Journal of Parkinson's disease [J Parkinsons Dis] 2026 Mar; Vol. 16 (2), pp. 332-350. Date of Electronic Publication: 2026 Feb 04. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II |
| Journal Info: | Publisher: IOS Press Country of Publication: United States NLM ID: 101567362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1877-718X (Electronic) Linking ISSN: 18777171 NLM ISO Abbreviation: J Parkinsons Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
